Oxycodon-Hcl Al (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodon-Hcl Al, is an opioid analgesic presented as a solid oral dosage form for systemic use. It is used to manage moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxycodon-Hcl Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxycodon-Hcl Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid that acts on the central nervous system to relieve pain across several clinical contexts.

- Acute postoperative pain: provides strong analgesia during the immediate recovery period after surgery. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: used when long‑term opioid therapy is deemed appropriate for conditions such as severe osteoarthritis. - Severe traumatic injury pain: reduces intense pain following major injuries. - Palliative care pain: contributes to comfort in end‑of‑life care.

Adverse reactions to oxycodone can vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: mild to moderate gastrointestinal upset. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness or sedation: increased sleepiness or reduced alertness. - Dizziness: sensation of light‑headedness or imbalance. - Dry mouth: reduced salivary flow causing oral dryness. - Pruritus: mild itching without rash.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Opioid use disorder: dependence or addiction with misuse potential. - Seizures: rare occurrence of convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing oxycodone, clinicians should evaluate patient history and monitor for potential risks.

- Assess pain severity and prior opioid exposure: ensure appropriate indication before initiating therapy. - Evaluate respiratory function: patients with compromised breathing need close observation. - Review concomitant CNS depressants: avoid additive sedation or respiratory effects. - Monitor for signs of dependence or misuse: implement risk mitigation strategies. - Adjust dose in renal or hepatic impairment: consider reduced clearance. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Oxycodone may interact with several medication groups, requiring careful management.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression and sedation. - CNS depressants (e.g., barbiturates, alcohol): additive central nervous system depression. - MAO inhibitors: may precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase oxy‑hydroxy‑oxycodone levels. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): alter metabolism and may reduce analgesic effect. - Anticholinergic agents: may exacerbate constipation. - Diuretics: can enhance hypotensive effects. - Antihistamines: increase risk of sedation.